Is BriaCell Therapeutics Stock a Good Investment?
BriaCell Therapeutics Investment Advice | BCTXW |
- Examine BriaCell Therapeutics' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research BriaCell Therapeutics' leadership team and their track record. Good management can help BriaCell Therapeutics navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact BriaCell Therapeutics' business and its evolving consumer preferences.
- Compare BriaCell Therapeutics' performance and market position to its competitors. Analyze how BriaCell Therapeutics is positioned in terms of product offerings, innovation, and market share.
- Check if BriaCell Therapeutics pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about BriaCell Therapeutics' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in BriaCell Therapeutics Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if BriaCell Therapeutics Corp is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Sell | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine BriaCell Therapeutics Stock
Researching BriaCell Therapeutics' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if BriaCell Therapeutics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding BriaCell Therapeutics' research are outlined below:
| BriaCell Therapeutics is way too risky over 90 days horizon | |
| BriaCell Therapeutics has some characteristics of a very speculative penny stock | |
| BriaCell Therapeutics appears to be risky and price may revert if volatility continues | |
| BriaCell Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (4.93 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BriaCell Therapeutics generates negative cash flow from operations | |
| BriaCell Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: BriaCell Provides Update to its Board of Directors |
BriaCell Therapeutics' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 48.08 M.Market Cap |
|
BriaCell Therapeutics' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.68) | (0.64) | |
| Return On Capital Employed | (1.06) | (1.11) | |
| Return On Assets | (0.67) | (0.64) | |
| Return On Equity | 4.84 | 5.08 |
Determining BriaCell Therapeutics' profitability involves analyzing its financial statements and using various financial metrics to determine if BriaCell Therapeutics is a good buy. For example, gross profit margin measures BriaCell Therapeutics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of BriaCell Therapeutics' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in BriaCell Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BriaCell Therapeutics Corp. Check BriaCell Therapeutics' Beneish M Score to see the likelihood of BriaCell Therapeutics' management manipulating its earnings.
Evaluate BriaCell Therapeutics' management efficiency
BriaCell Therapeutics has return on total asset (ROA) of (1.2611) % which means that it has lost $1.2611 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.0601) %, meaning that it generated substantial loss on money invested by shareholders. BriaCell Therapeutics' management efficiency ratios could be used to measure how well BriaCell Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to climb to 5.08 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0.64). At this time, BriaCell Therapeutics' Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 1.3 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 1.2 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.28) | (0.26) | |
| Net Current Asset Value | 402 K | 357.4 K | |
| Tangible Asset Value | 675.2 K | 628.6 K | |
| Tangible Book Value Per Share | (0.29) | (0.28) | |
| Enterprise Value Over EBITDA | (3.44) | (3.62) | |
| Price Book Value Ratio | (31.28) | (29.72) | |
| Enterprise Value Multiple | (3.44) | (3.62) | |
| Price Fair Value | (31.28) | (29.72) | |
| Enterprise Value | 73.4 M | 77 M |
The management strategies employed by BriaCell Therapeutics' are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Beta 1.816 |
Basic technical analysis of BriaCell Stock
As of the 28th of November, BriaCell Therapeutics shows the Mean Deviation of 8.22, risk adjusted performance of 0.0455, and Downside Deviation of 12.93. BriaCell Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BriaCell Therapeutics semi deviation, jensen alpha, as well as the relationship between the Jensen Alpha and semi variance to decide if BriaCell Therapeutics is priced correctly, providing market reflects its regular price of 0.345 per share. As BriaCell Therapeutics appears to be a penny stock we also recommend to validate its total risk alpha numbers.Understand BriaCell Therapeutics' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing BriaCell Therapeutics' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0455 | |||
| Market Risk Adjusted Performance | 0.5717 | |||
| Mean Deviation | 8.22 | |||
| Semi Deviation | 10.17 | |||
| Downside Deviation | 12.93 | |||
| Coefficient Of Variation | 2113.92 | |||
| Standard Deviation | 11.34 | |||
| Variance | 128.63 | |||
| Information Ratio | 0.0358 | |||
| Jensen Alpha | 0.4136 | |||
| Total Risk Alpha | (1.26) | |||
| Sortino Ratio | 0.0314 | |||
| Treynor Ratio | 0.5617 | |||
| Maximum Drawdown | 49.77 | |||
| Value At Risk | (15.79) | |||
| Potential Upside | 18.75 | |||
| Downside Variance | 167.22 | |||
| Semi Variance | 103.39 | |||
| Expected Short fall | (10.22) | |||
| Skewness | 0.1364 | |||
| Kurtosis | 1.21 |
| Risk Adjusted Performance | 0.0455 | |||
| Market Risk Adjusted Performance | 0.5717 | |||
| Mean Deviation | 8.22 | |||
| Semi Deviation | 10.17 | |||
| Downside Deviation | 12.93 | |||
| Coefficient Of Variation | 2113.92 | |||
| Standard Deviation | 11.34 | |||
| Variance | 128.63 | |||
| Information Ratio | 0.0358 | |||
| Jensen Alpha | 0.4136 | |||
| Total Risk Alpha | (1.26) | |||
| Sortino Ratio | 0.0314 | |||
| Treynor Ratio | 0.5617 | |||
| Maximum Drawdown | 49.77 | |||
| Value At Risk | (15.79) | |||
| Potential Upside | 18.75 | |||
| Downside Variance | 167.22 | |||
| Semi Variance | 103.39 | |||
| Expected Short fall | (10.22) | |||
| Skewness | 0.1364 | |||
| Kurtosis | 1.21 |
Consider BriaCell Therapeutics' intraday indicators
BriaCell Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BriaCell Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
BriaCell Therapeutics time-series forecasting models is one of many BriaCell Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BriaCell Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
BriaCell Stock media impact
Far too much social signal, news, headlines, and media speculation about BriaCell Therapeutics that are available to investors today. That information is available publicly through BriaCell media outlets and privately through word of mouth or via BriaCell internal channels. However, regardless of the origin, that massive amount of BriaCell data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of BriaCell Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BriaCell Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BriaCell Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BriaCell Therapeutics alpha.
BriaCell Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards BriaCell Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
BriaCell Therapeutics Corporate Management
| FACP MD | Founder Director | Profile | |
| Miguel LopezLago | Chief Officer | Profile | |
| Farrah Dean | Mang Devel | Profile | |
| MD MPH | Chief Officer | Profile |
Additional Tools for BriaCell Stock Analysis
When running BriaCell Therapeutics' price analysis, check to measure BriaCell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BriaCell Therapeutics is operating at the current time. Most of BriaCell Therapeutics' value examination focuses on studying past and present price action to predict the probability of BriaCell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BriaCell Therapeutics' price. Additionally, you may evaluate how the addition of BriaCell Therapeutics to your portfolios can decrease your overall portfolio volatility.